Cargando…
Bringing Advanced Therapies for Parkinson’s Disease to the Clinic: The Scientist’s Perspective
After many years of preclinical development, cell and gene therapies have advanced from research tools in the lab to clinical-grade products for patients, and today they constitute more than a quarter of all new Phase I clinical trials for Parkinson’s disease. Whereas efficacy has been convincingly...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
IOS Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543246/ https://www.ncbi.nlm.nih.gov/pubmed/34250954 http://dx.doi.org/10.3233/JPD-212685 |